Liver sinusoidal endothelial cells (LSECs) play a fundamental role in maintaining liver homeostasis and responding to pathogens. However, primary LSECs are challenging to culture, as they tend to lose their fenestrated phenotype rapidly in vitro. Immortalization techniques, such as introducing SV40T or hTERT, allow the establishment of cell lines that retain essential characteristics while providing extended growth capabilities. This innovation addresses the logistical issues related to sourcing primary cells, allowing researchers to conduct consistent and reproducible experiments. Application in Cancer ResearchStudies demonstrate the significance of HHSECs in understanding liver metastasis, especially in colorectal cancer (CRC). Research indicates that proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a role in enhancing endothelial activation during metastatic processes. By utilizing HHSEC models, researchers found that conditioned media from CRC cells upregulates PCSK9, leading to increased cellular proliferation and migration, contributing to the formation of a cancer-supportive environment. Targeting PCSK9 presents a potential therapeutic strategy to impede liver metastasis in CRC patients. ConclusionImmortalized Human Hepatic Sinusoidal Endothelial Cells (CSC-I2044Z) are invaluable resources for researchers investigating liver function and disease mechanisms. Their ability to serve as stable and functional models enhances our understanding of liver dynamics and aids in the development of therapeutic strategies for liver-related conditions.
- Current Events
- Upcoming Events
- Past Events

